It's true that the stock was recently trading in the $2 range and now it is in the $1.50 range which is about a 25% drop, but the pullback is not specific to DVAX stock, the whole Biotech sector is down. For example, Celgene is down 20%, and it is a rapidly growing company. This sector will come back and reach new highs in time. This recent pullback in DVAX, Celgene, or the Biotech Sector, is not the fault of Eddie Gray as some have concluded, but is a general market trend.
Personally, I am very happy with what Eddie Gray has done for the company since his arrival. As soon as he got here, we were denied FDA approval, but that had nothing to do with him. We were trading at 98 cents last summer, but now are trading at $1.50--a 50% increase. He has made smart moves and his timing is good. Along with our senior management, he is doing a great job. Until I see substantial evidence I should do otherwise, I am behind him 100%. Now bring on the reverse split, and let's continue moving this company forward.